For: | Drosos P, Johnsen E, Bartz-Johannessen CA, Larsen TK, Reitan SK, Rettenbacher M, Kroken RA. Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness. World J Psychiatry 2022; 12(3): 521-532 [PMID: 35433321 DOI: 10.5498/wjp.v12.i3.521] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v12/i3/521.htm |
Number | Citing Articles |
1 |
Mohammadamin Parsaei, Amirmahdi Sheipouri, Paniz Partovifar, Maryam Shahriarinamin, Sheida Mobader Sani, Morvarid Taebi, Alireza Arvin. Diffusion magnetic resonance imaging for treatment response prediction in schizophrenia spectrum disorders: A systematic review. Psychiatry Research: Neuroimaging 2024; 342: 111841 doi: 10.1016/j.pscychresns.2024.111841
|
2 |
Petros Drosos, Erik Johnsen, Christoffer Andreas Bartz-Johannessen, Tor Ketil Larsen, Solveig Klæbo Reitan, Maria Rettenbacher, Rune Andreas Kroken. Remission in schizophrenia spectrum disorders: A randomized trial of amisulpride, aripiprazole and olanzapine. Schizophrenia Research 2024; 271: 9 doi: 10.1016/j.schres.2024.06.047
|
3 |
Eirik Kjelby, Rolf Gjestad, Farivar Fathian, Igne Sinkeviciute, Renata Alisauskiene, Liss Anda, Else-Marie Løberg, Solveig Klæbo Reitan, Inge Joa, Tor Ketil Larsen, Maria Rettenbacher, Jan Øystein Berle, Ole Bernt Fasmer, Rune Andreas Kroken, Erik Johnsen. Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders. Journal of Clinical Psychopharmacology 2023; 43(3): 246 doi: 10.1097/JCP.0000000000001679
|